NCT00743340 - Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 22, 2005

Primary Completion Date

February 13, 2017

Study Completion Date

February 13, 2017

Conditions

HIV-1 Infection

Interventions

DRUG

Emtricitabine

6 mg/kg capsule once daily, up to a maximum dose of 200 mg once daily, or 10 mg/mL oral solution once daily, up to a maximum of 240 mg once daily

Trial Locations (2)

Themba Lethu Clinic, Helen Joseph Hospital, Westdene, Johannesburg

Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto